These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 1311070)

  • 1. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
    Tan SH; Gloss B; Bernard HU
    Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
    Dong G; Broker TR; Chow LT
    J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.
    Gloss B; Bernard HU
    J Virol; 1990 Nov; 64(11):5577-84. PubMed ID: 2170687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
    Tan SH; Leong LE; Walker PA; Bernard HU
    J Virol; 1994 Oct; 68(10):6411-20. PubMed ID: 8083979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter.
    Demeret C; Yaniv M; Thierry F
    J Virol; 1994 Nov; 68(11):7075-82. PubMed ID: 7933089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
    Hoppe-Seyler F; Butz K
    Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16.
    Dong XP; Pfister H
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2097-2101. PubMed ID: 10466808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
    Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
    J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure.
    Ham J; Steger G; Yaniv M
    EMBO J; 1994 Jan; 13(1):147-57. PubMed ID: 8306958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
    Thierry F; Howley PM
    New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.
    Stubenrauch F; Leigh IM; Pfister H
    J Virol; 1996 Jan; 70(1):119-26. PubMed ID: 8523515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.
    Stubenrauch F; Zobel T; Iftner T
    J Virol; 2001 May; 75(9):4139-49. PubMed ID: 11287563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition.
    Zhan D; Santin AD; Liu Y; Parham GP; Li C; Meyers C; Hermonat PL
    J Biol Chem; 1999 Oct; 274(44):31619-24. PubMed ID: 10531369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.
    Dostatni N; Lambert PF; Sousa R; Ham J; Howley PM; Yaniv M
    Genes Dev; 1991 Sep; 5(9):1657-71. PubMed ID: 1653173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.
    Demeret C; Desaintes C; Yaniv M; Thierry F
    J Virol; 1997 Dec; 71(12):9343-9. PubMed ID: 9371593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription.
    Li R; Knight JD; Jackson SP; Tjian R; Botchan MR
    Cell; 1991 May; 65(3):493-505. PubMed ID: 1850324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
    Butz K; Hoppe-Seyler F
    J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
    Cripe TP; Alderborn A; Anderson RD; Parkkinen S; Bergman P; Haugen TH; Pettersson U; Turek LP
    New Biol; 1990 May; 2(5):450-63. PubMed ID: 1963084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.
    Steger G; Corbach S
    J Virol; 1997 Jan; 71(1):50-8. PubMed ID: 8985322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
    Oh ST; Kyo S; Laimins LA
    J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.